These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 14663275)

  • 1. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
    Marcus KJ; Shamberger R; Litman H; von Allmen D; Grupp SA; Nancarrow CM; Goldwein J; Grier HE; Diller L
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):934-40. PubMed ID: 14663275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
    von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
    J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
    Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
    George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
    J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
    Sibley GS; Mundt AJ; Goldman S; Nachman J; Reft C; Weichselbaum RR; Hallahan DE; Johnson L
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1127-35. PubMed ID: 7607934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
    Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
    Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.
    Haas-Kogan DA; Swift PS; Selch M; Haase GM; Seeger RC; Gerbing RB; Stram DO; Matthay KK
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):28-39. PubMed ID: 12694821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse in the skull after myeloablative therapy for high-risk neuroblastoma.
    Sangthawan D; DesRosiers PM; Randall ME; Robertson K; Goebel S; Fallon R
    Pediatr Hematol Oncol; 2003; 20(1):23-30. PubMed ID: 12687750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
    Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control with multimodality therapy for stage 4 neuroblastoma.
    Wolden SL; Gollamudi SV; Kushner BH; LaQuaglia M; Kramer K; Rosen N; Abramson S; Cheung NV
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):969-74. PubMed ID: 10705019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.
    Kletzel M; Katzenstein HM; Haut PR; Yu AL; Morgan E; Reynolds M; Geissler G; Marymount MH; Liu D; Kalapurakal JA; Shore RM; Bardo DM; Schmoldt J; Rademaker AW; Cohn SL
    J Clin Oncol; 2002 May; 20(9):2284-92. PubMed ID: 11980999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.
    Granger M; Grupp SA; Kletzel M; Kretschmar C; Naranjo A; London WB; Diller L
    Pediatr Blood Cancer; 2012 Nov; 59(5):902-7. PubMed ID: 22744917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
    Kushner BH; Wolden S; LaQuaglia MP; Kramer K; Verbel D; Heller G; Cheung NK
    J Clin Oncol; 2001 Jun; 19(11):2821-8. PubMed ID: 11387353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.
    Saarinen-Pihkala UM; Hovi L; Koivusalo A; Jahnukainen K; Karikoski R; Sariola H; Wikström S
    Pediatr Blood Cancer; 2012 Dec; 59(7):1190-7. PubMed ID: 22492714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
    Kreissman SG; Seeger RC; Matthay KK; London WB; Sposto R; Grupp SA; Haas-Kogan DA; Laquaglia MP; Yu AL; Diller L; Buxton A; Park JR; Cohn SL; Maris JM; Reynolds CP; Villablanca JG
    Lancet Oncol; 2013 Sep; 14(10):999-1008. PubMed ID: 23890779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.
    Pradhan KR; Johnson CS; Vik TA; Sender LS; Kreissman SG
    Pediatr Blood Cancer; 2006 Jun; 46(7):793-802. PubMed ID: 16206215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
    Valteau-Couanet D; Le Deley MC; Bergeron C; Ducassou S; Michon J; Rubie H; Le Teuff G; Coze C; Plantaz D; Sirvent N; Bouzy J; Chastagner P; Hartmann O
    Pediatr Blood Cancer; 2014 Jun; 61(6):977-81. PubMed ID: 23970413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.